İçli, F.; Altundağ, K.; Akbulut, H.; Paydaş, S.; Başaran, G.; Saip, P.; Doğu, G.G.; Eralp, Y.; Uslu, R.; Sevinç, A.; Onur, H.; Mandel, N.M.; Sezgin, C.; Altınbaş, M.; Güler, N.; Işıkdoğan, A.; Gökmen, E.; Uygun, K.; Üstüner, Z.; Yaren, Arzu; Demirkan, B.; Coşkun, U.; Ata, A.; Özkan, M.; Arican, A.
(Springer-Verlag Tokyo, 2015)
Background: Optimal duration of adjuvant trastuzumab in early breast cancer is an unresolved issue. In this observational study, we compared the outcome of 9 weeks and 1 year adjuvant trastuzumab in early breast cancer ...